BENEFICIENT - CLASS A (BENF) Fundamental Analysis & Valuation

NASDAQ:BENF • US08178Q5071

Current stock price

3.63 USD
0 (0%)
Last:

This BENF fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. BENF Profitability Analysis

1.1 Basic Checks

  • BENF had negative earnings in the past year.
  • BENF had a negative operating cash flow in the past year.
  • BENF had negative earnings in 4 of the past 5 years.
  • In the past 5 years BENF always reported negative operating cash flow.
BENF Yearly Net Income VS EBIT VS OCF VS FCFBENF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 -500M -1B -1.5B -2B

1.2 Ratios

  • BENF has a Return On Assets of -20.13%. This is amonst the worse of the industry: BENF underperforms 90.79% of its industry peers.
Industry RankSector Rank
ROA -20.13%
ROE N/A
ROIC N/A
ROA(3y)-186.26%
ROA(5y)-113.05%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BENF Yearly ROA, ROE, ROICBENF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 500 -500

1.3 Margins

  • BENF's Operating Margin has declined in the last couple of years.
  • BENF does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3Y-16.43%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BENF Yearly Profit, Operating, Gross MarginsBENF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 500 -500 1K 1.5K 2K

0

2. BENF Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, BENF has more shares outstanding
  • Compared to 5 years ago, BENF has less shares outstanding
  • Compared to 1 year ago, BENF has a worse debt to assets ratio.
BENF Yearly Shares OutstandingBENF Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
BENF Yearly Total Debt VS Total AssetsBENF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • Based on the Altman-Z score of -10.43, we must say that BENF is in the distress zone and has some risk of bankruptcy.
  • BENF has a Altman-Z score of -10.43. This is amonst the worse of the industry: BENF underperforms 89.96% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -10.43
ROIC/WACCN/A
WACCN/A
BENF Yearly LT Debt VS Equity VS FCFBENF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • A Current Ratio of 0.02 indicates that BENF may have some problems paying its short term obligations.
  • The Current ratio of BENF (0.02) is worse than 94.56% of its industry peers.
  • A Quick Ratio of 0.02 indicates that BENF may have some problems paying its short term obligations.
  • BENF has a Quick ratio of 0.02. This is amonst the worse of the industry: BENF underperforms 94.56% of its industry peers.
Industry RankSector Rank
Current Ratio 0.02
Quick Ratio 0.02
BENF Yearly Current Assets VS Current LiabilitesBENF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

1

3. BENF Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 62.05% over the past year.
  • BENF shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -38.90%.
EPS 1Y (TTM)62.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.23%
Revenue 1Y (TTM)-38.9%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%322.49%

3.2 Future

  • Based on estimates for the next years, BENF will show a very strong growth in Earnings Per Share. The EPS will grow by 34.63% on average per year.
  • The Revenue is expected to decrease by -6.51% on average over the next years.
EPS Next Y-104.29%
EPS Next 2Y34.63%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-32.77%
Revenue Next 2Y-6.51%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

BENF Yearly Revenue VS EstimatesBENF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 50M -50M 100M -100M
BENF Yearly EPS VS EstimatesBENF Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -10 -20 -30

1

4. BENF Valuation Analysis

4.1 Price/Earnings Ratio

  • BENF reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year BENF is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BENF Price Earnings VS Forward Price EarningsBENF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BENF Per share dataBENF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -20 -40 -60

4.3 Compensation for Growth

  • BENF's earnings are expected to grow with 34.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.63%
EPS Next 3YN/A

0

5. BENF Dividend Analysis

5.1 Amount

  • No dividends for BENF!.
Industry RankSector Rank
Dividend Yield 0%

BENF Fundamentals: All Metrics, Ratios and Statistics

BENEFICIENT - CLASS A

NASDAQ:BENF (3/26/2026, 11:31:19 AM)

3.63

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-17
Earnings (Next)N/A
Inst Owners3.74%
Inst Owner Change-98.95%
Ins Owners2.17%
Ins Owner Change43%
Market Cap51.58M
Revenue(TTM)-27.68M
Net Income(TTM)-68.02M
AnalystsN/A
Price Target10.2 (180.99%)
Short Float %27.57%
Short Ratio0.55
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)123.11%
Min EPS beat(2)92.46%
Max EPS beat(2)153.76%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)29.03%
Min Revenue beat(2)-118.65%
Max Revenue beat(2)176.72%
Revenue beat(4)1
Avg Revenue beat(4)-102.9%
Min Revenue beat(4)-294.39%
Max Revenue beat(4)176.72%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-37.5%
PT rev (3m)400%
EPS NQ rev (1m)-22.93%
EPS NQ rev (3m)-819.05%
EPS NY rev (1m)-478.05%
EPS NY rev (3m)-2167.07%
Revenue NQ rev (1m)0.04%
Revenue NQ rev (3m)-0.25%
Revenue NY rev (1m)48.91%
Revenue NY rev (3m)-1.21%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-60.92
EYN/A
EPS(NY)-3.48
Fwd EYN/A
FCF(TTM)-3.05
FCFYN/A
OCF(TTM)-3.04
OCFYN/A
SpS-1.95
BVpS-12.65
TBVpS-13.56
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -20.13%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-186.26%
ROA(5y)-113.05%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-16.43%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover-0.08
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 22.7%
Cap/Sales -0.79%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.02
Quick Ratio 0.02
Altman-Z -10.43
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)56.34%
Cap/Depr(5y)134.67%
Cap/Sales(3y)5.87%
Cap/Sales(5y)13.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)62.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.23%
EPS Next Y-104.29%
EPS Next 2Y34.63%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-38.9%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%322.49%
Revenue Next Year-32.77%
Revenue Next 2Y-6.51%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y40.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y39.13%
OCF growth 3YN/A
OCF growth 5YN/A

BENEFICIENT - CLASS A / BENF Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BENEFICIENT - CLASS A?

ChartMill assigns a fundamental rating of 0 / 10 to BENF.


What is the valuation status of BENEFICIENT - CLASS A (BENF) stock?

ChartMill assigns a valuation rating of 1 / 10 to BENEFICIENT - CLASS A (BENF). This can be considered as Overvalued.


How profitable is BENEFICIENT - CLASS A (BENF) stock?

BENEFICIENT - CLASS A (BENF) has a profitability rating of 0 / 10.


Can you provide the financial health for BENF stock?

The financial health rating of BENEFICIENT - CLASS A (BENF) is 0 / 10.